Literature DB >> 10694951

Prognostic significance of proliferative and apoptotic markers in oral tongue squamous cell carcinomas.

X Xie1, P De Angelis, O P Clausen, M Boysen.   

Abstract

The prognostic impact of proliferative and apoptotic markers was studied in 85 T1-4 oral tongue squamous cell carcinomas (SCCs). Ki67 immunoreactivity and AgNOR counts, including mean AgNOR counts (mAgNOR) and the percentage of nuclei with more than one AgNOR (pAgNOR > 1), were used as proliferative parameters. The apoptotic index (AI) was assessed using the TUNEL method. Bax expression was detected immunohistochemically and scored. Bax expression correlated positively with AI (p = 0.0122). Ki67 correlated with both pAgNOR > 1 (p = 0.0042) and mAgNOR (p = 0.0189). Low Bax expression and low AI correlated significantly with the disease-free period (p = 0.0001 and p = 0.0024, respectively). High values for Ki67, pAgNOR > 1 and mAgNOR correlated with poor prognosis (p = 0.0021, p = 0.0001 and p = 0.0244, respectively). Combinations of proliferative and apoptotic parameters were stronger predictors than individual parameters (p < 0.0001). pAgNOR > 1-Bax expression appeared to be the best combination (p < 0.0001). We conclude that proliferative and apoptotic markers, especially their combinations, have prognostic value in tongue SCC.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10694951     DOI: 10.1016/s1368-8375(99)00024-x

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  12 in total

1.  Apoptosis is the essential target of selective pressure against p53, whereas loss of additional p53 functions facilitates carcinoma progression.

Authors:  Xiangdong Lu; Chunyu Yang; Chaoying Yin; Terry Van Dyke; Karl Simin
Journal:  Mol Cancer Res       Date:  2011-03-08       Impact factor: 5.852

2.  CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas.

Authors:  Henning Hanken; Alexander Gröbe; Georg Cachovan; Ralf Smeets; Ronald Simon; Guido Sauter; Max Heiland; Marco Blessmann
Journal:  Clin Oral Investig       Date:  2013-03-15       Impact factor: 3.573

3.  Erlotinib, erlotinib-sulindac versus placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck cancer.

Authors:  Neil D Gross; Julie E Bauman; William E Gooding; William Denq; Sufi M Thomas; Lin Wang; Simion Chiosea; Brian L Hood; Melanie S Flint; Mai Sun; Thomas P Conrads; Robert L Ferris; Jonas T Johnson; Seungwon Kim; Athanassios Argiris; Lori Wirth; Marina N Nikiforova; Jill M Siegfried; Jennifer R Grandis
Journal:  Clin Cancer Res       Date:  2014-04-11       Impact factor: 12.531

4.  Prognostic value of 99mTc-HYNIC annexin-V imaging in squamous cell carcinoma of the head and neck.

Authors:  David Loose; Hubert Vermeersch; Filip De Vos; Philippe Deron; Guido Slegers; Christophe Van de Wiele
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-29       Impact factor: 9.236

5.  Vascular endothelial growth factor and ki-67 antigen expression in relation to age and gender in oral squamous cell carcinoma.

Authors:  Noushin Jalayer Naderi; Farrokh Tirgari; Farzin Esmaili; Faranak Paktinat; Zahra Keshavarz
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2012-09-01

6.  The expression of p53-induced protein with death domain (Pidd) and apoptosis in oral squamous cell carcinoma.

Authors:  G Bradley; S Tremblay; J Irish; C MacMillan; G Baker; P Gullane; S Benchimol
Journal:  Br J Cancer       Date:  2007-04-17       Impact factor: 7.640

7.  Evaluation of histomorphological and immunohistochemical parameters as biomarkers of cervical lymph node metastasis in squamous cell carcinoma of oral cavity: A retrospective study.

Authors:  T N Suresh; A Hemalatha; M L Harendra Kumar; S M Azeem Mohiyuddin
Journal:  J Oral Maxillofac Pathol       Date:  2015 Jan-Apr

8.  A study on the relationship between clinical features with Ki67 expression and eosinophil cells infiltration in oral squamous cell carcinoma.

Authors:  Noushin Jalayer Naderi; Farrokh Tirgari; Mohammad Javad KharaziFard; Fateme Farahani Parsa
Journal:  Med J Islam Repub Iran       Date:  2014-10-20

9.  99mTc-HYNIC-Annexin A5 in Oncology: Evaluating Efficacy of Anti-Cancer Therapies.

Authors:  Frédéric L W V J Schaper; Chris P Reutelingsperger
Journal:  Cancers (Basel)       Date:  2013-05-15       Impact factor: 6.639

10.  Ki-67 expression predicts locoregional recurrence in stage I oral tongue carcinoma.

Authors:  D Wangsa; M Ryott; E Avall-Lundqvist; F Petersson; G Elmberger; J Luo; T Ried; G Auer; E Munck-Wikland
Journal:  Br J Cancer       Date:  2008-09-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.